Save the Date

November 18 – 19, 2020 • Harvard Medical School, Boston, MA

Organizing Committee

The 16th Annual Personalized Medicine Conference is being organized by a cross-industry, cross-disciplinary panel, made up of providers, payers, educators, researchers and other stakeholders — all of whom believe that collaborative dialogue is essential to the advancement of personalized medicine.


Chair

EDWARD ABRAHAMS, PH.D.
President, Personalized Medicine Coalition

Bonnie J. Addario
Co-Founder, Chair, GO2 Foundation for Lung Cancer

Antonio L. Andreu, M.D., Ph.D.
Scientific Director, EATRIS (European Infrastructure for Translational Medicine)

Mary Bordoni
Director, Alliance Development, Biotechnology Innovation Organization

William S. Dalton, Ph.D., M.D.
Founder, Executive Chairman, M2Gen

Stephen L. Eck, M.D., Ph.D.
Chief Medical Officer, Immatics US

Okan Ekinci, M.D., M.B.A.
Chief Medical Officer, Roche Diagnostics Information Solutions

Lori Frank, Ph.D.
Memory Screening Advisory Board Member, Alzheimer’s Foundation of America

Richard Hamermesh, D.B.A.
Co-Faculty Chair, Harvard Business School Kraft Precision Medicine Accelerator

Kris Joshi, Ph.D.
Executive Vice President, President, Network Solutions, Change Healthcare

Richard Knight
President, American Association of Kidney Patients

Dan Leonard
President, National Pharmaceutical Council

Anne-Marie Martin, Ph.D.
Senior Vice President, Global Head of Precision Medicine, Novartis

Susan McClure
Founder, CEO, Genome Creative

Howard McLeod, Pharm.D.

Tom Miller
Founder, Managing Partner, GreyBird Ventures LLC

Lincoln Nadauld, M.D., Ph.D.
Chief, Precision Health, Intermountain Healthcare

Michael J. Pellini, M.D.
Managing Partner, Section 32

Anna G. Pugh
Senior Manager, Issue Advocacy, Genentech

Ammar Qadan
Vice President, Global Head of Market Access, Illumina

Marshall Ruffin, M.D.
CEO, Salutary

Hakan Sakul, Ph.D.
Vice President, Head of Diagnostics, Worldwide Research & Development, Pfizer

Michael Sherman, M.D.
Chief Medical Officer, Senior Vice President, Harvard Pilgrim Health Care

Lauren Silvis
Senior Vice President, External Affairs, Tempus

Ralph Snyderman, M.D.
James B. Duke Professor of Medicine, Duke University

Fintan Steele
Chief Corporate Communications and Culture Officer, SomaLogic

Mark P. Stevenson
Executive Vice President, Chief Operating Officer, Thermo Fisher Scientific

Bernadette Toner
CEO, GenomeWeb

Apostolia M. Tsimberidou, M.D., Ph.D.
Tenured Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Alex Vadas, Ph.D.
Managing Director, Partner, LEK Consulting

Werner Verbiest
Strategic Partnerships and Alliances Leader, Janssen Pharmaceutical Companies of Johnson & Johnson

Jay G. Wohlgemuth, M.D.
Chief Medical Officer, Senior Vice President, Quest Diagnostics